Central sensitization associated with low fetal hemoglobin levels in adults with sickle cell anemia

Background and aims Pain is the hallmark of sickle cell anemia (SCA), presenting as recurrent acute events or chronic pain. Central sensitization, or enhanced excitability of the central nervous system, alters pain processing and contributes to the maintenance of chronic pain. Individuals with SCA demonstrate enhanced sensitivity to painful stimuli however central mechanisms of pain have not been fully explored. We hypothesized that adults with SCA would show evidence of central sensitization as observed in other diseases of chronic pain. Methods We conducted a prospective study of static and dynamic quantitative sensory tests in 30 adults with SCA and 30 matched controls. Results Static thermal testing using cold stimuli showed lower pain thresholds ( p =0.04) and tolerance ( p =0.04) in sickle cell subjects, but not for heat. However, SCA subjects reported higher pain ratings with random heat pulses ( p p =0.002). Similarly, with the use of pressure pain stimuli, sickle cell subjects reported higher pain ratings ( p =0.04), but not higher pressure pain tolerance/thresholds or allodynia to light tactile stimuli. Temporal summation pain score changes using 2 pinprick probes (256 and 512mN) were significantly greater ( p =0.004 and p =0.008) with sickle cell, and delayed recovery was associated with lower fetal hemoglobin ( p =0.002 and 0.003). Conclusions Exaggerated temporal summation responses provide evidence of central sensitization in SCA. Implications The association with fetal hemoglobin suggests this known SCA modifier may have a therapeutic role in modulating central sensitization.